Skeletal muscle weakness in osteogeneis imperfecta mice

Matrix Biology

Volumn 29, Issue 7, 2010, Pages 638-644

  Gentry, Bettina A ^a   Ferreira, J Andries ^a   McCambridge, Amanda J ^b   Brown, Marybeth ^a   Phillips, Charlotte L ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

Muscle weight; Peak tetanic force; Skeletal muscle; Type I collagen

Indexed keywords

COLLAGEN TYPE 1; FIBRILLAR COLLAGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; HISTOPATHOLOGY; MALE; MOUSE; MUSCLE MASS; MUSCLE WEAKNESS; MUTATION; NONHUMAN; OSTEOGENESIS IMPERFECTA; PATHOLOGY; PHENOTYPE; PLANTARIS MUSCLE; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; SKELETAL MUSCLE; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE;

ANIMALS; BODY WEIGHT; COLLAGEN; FEMALE; FIBRILLAR COLLAGENS; FRAMESHIFT MUTATION; HETEROZYGOTE; HOMOZYGOTE; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUSCLE CONTRACTION; MUSCLE FIBERS, SKELETAL; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MYOSINS; OSTEOGENESIS IMPERFECTA;

MUS;

EID: 77957751317     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2010.06.006     Document Type: Article

References (39)

1. Baldridge D., Schwarze U., Morello R., et al. CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum. Mutat. 2008, 29:1435-1442.
2. Barnes A.M., Chang W., Morello R., et al. Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J. Med. 2006, 355:2757-2764.
3. Barnes A.M., Carter E.M., Cabral W.A., et al. Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. N Engl J. Med. 2010, 362:521-528.
4. Basel D., Steiner R.D. Osteogenesis imperfecta: recent findings shed new light on this once well-understood condition. Genet. Med. 2009, 11:375-385.
5. Boot A.M., de Coo R.F., Pals G., et al. Muscle weakness as presenting symptom of osteogenesis imperfecta. Eur. J. Pediatr. 2006, 165:392-394.
6. Brown M., Ning J., Ferreira J.A., et al. Estrogen receptor-alpha and -beta and aromatase knockout effects on lower limb muscle mass and contractile function in female mice. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E854-E861.
7. Burkholder T.J., Fingado B., Baron S., et al. Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. J. Morphol. 1994, 221:177-190.
8. Byers P.H. Osteogenesis Imperfecta 1993, Wiley-Liss, New York. 2 ed.
9. Byers P.H. Disorders of collagen biosynthesis and structure. Metabolic and Molecular Bases of Inherited Disease 2001, 5241-5285. McGraw-Hill. 8th Ed. C. Scriver, A. Beadudet, W. Sly, D. Valle, B. Childs, B. Vogelstein (Eds.).
10. Cabral W.A., Chang W., Barnes A.M., et al. Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat. Genet. 2007, 39:359-365.
11. Camacho N.P., Hou L., Toledano T.R., et al. The material basis for reduced mechanical properties in oim mice bones. J. Bone Miner. Res. 1999, 14:264-272.
12. Carleton S.M., McBride D.J., Carson W.L., et al. Role of genetic background in determining phenotypic severity throughout postnatal development and at peak bone mass in Col1a2 deficient mice (oim). Bone 2008, 42:681-694.
13. Carson F.L. Histotechnology: a Self-Instructional Text 1997, ASCP Press, Chicago. 2nd ed.
14. Chipman S.D., Sweet H.O., McBride D.J., et al. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc. Natl Acad. Sci. U. S. A. 1993, 90:1701-1705.
15. Choi J.W., Sutor S.L., Lindquist L., et al. Severe osteogenesis imperfecta in cyclophilin B-deficient mice. PLoS Genet. 2009, 5:e1000750.
16. Conover W.J., Iman R.L. Analysis of covariance using the rank transformation. Biometrics 1982, 38:715-724.
17. Daley E., Streeten E.A., Sorkin J.D., et al. Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model. J. Bone Miner. Res. 2010, 25:247-261.
18. Engelbert R.H., van der Graaf Y., van Empelen R., et al. Osteogenesis imperfecta in childhood: impairment and disability. Pediatrics 1997, 99:E3.
19. Forlino A., Porter F.D., Lee E.J., et al. Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice. J. Biol. Chem. 1999, 274:37923-37931.
20. Gajko-Galicka A. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans. Acta Biochim. Pol. 2002, 49:433-441.
21. Glaser B.W., You G., Zhang M., et al. Relative proportions of hybrid fibers are unaffected by 6weeks of running exercise in mouse skeletal muscles. Exp. Physiol. 2010, 95:211-221.
22. Hesselink R.P., Gorselink M., Schaart G., et al. Impaired performance of skeletal muscle in alpha-glucosidase knockout mice. Muscle Nerve 2002, 25:873-883.
23. Lieber R.L. Skeletal Muscle Structure, Function & Plasticity: the Physiological Basis of Rehabilitation 2002, Lippincott Williams & Wilkins, Philadelphia. 2nd ed.
24. Marini J.C., Cabral W.A., Barnes A.M., et al. Components of the collagen prolyl 3-hydroxylation complex are crucial for normal bone development. Cell Cycle 2007, 6:1675-1681.
25. Marini J.C., Forlino A., Cabral W.A., et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum. Mutat. 2007, 28:209-221.
26. McBride D.J., Choe V., Shapiro J.R., et al. Altered collagen structure in mouse tail tendon lacking the alpha 2(I) chain. J. Mol. Biol. 1997, 270:275-284.
27. McBride D.J., Shapiro J.R., Dunn M.G. Bone geometry and strength measurements in aging mice with the oim mutation. Calcif. Tissue Int. 1998, 62:172-176.
28. Misof K., Landis W.J., Klaushofer K., et al. Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress. J. Clin. Invest. 1997, 100:40-45.
29. Morello R., Bertin T.K., Chen Y., et al. CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 2006, 127:291-304.
30. Nicholls A.C., Osse G., Schloon H.G., et al. The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta. J. Med. Genet. 1984, 21:257-262.
31. Phillips C.L., Bradley D.A., Schlotzhauer C.L., et al. Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density. Bone 2000, 27:219-226.
32. Pihlajaniemi T., Dickson L.A., Pope F.M., et al. Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation. J. Biol. Chem. 1984, 259:12941-12944.
33. Saban J., Zussman M.A., Havey R., et al. Heterozygous oim mice exhibit a mild form of osteogenesis imperfecta. Bone 1996, 19:575-579.
34. Sims T.J., Miles C.A., Bailey A.J., et al. Properties of collagen in OIM mouse tissues. Connect. Tissue Res. 2003, 44(Suppl 1):202-205.
35. Suskauer S.J., Cintas H.L., Marini J.C., et al. Temperament and physical performance in children with osteogenesis imperfecta. Pediatrics 2003, 111:E153-E161.
36. Takken T., Terlingen H.C., Helders P.J., et al. Cardiopulmonary fitness and muscle strength in patients with osteogenesis imperfecta type I. J. Pediatr. 2004, 145:813-818.
37. Van Dijk F.S., Pals G., Van Rijn R.R., et al. Classification of osteogenesis imperfecta revisited. Eur. J. Med. Genet. 2009, 53:1-5.
38. Weis S.M., Emery J.L., Becker K.D., et al. Myocardial mechanics and collagen structure in the osteogenesis imperfecta murine (oim). Circ. Res. 2000, 87:663-669.
39. Willaert A., Malfait F., Symoens S., et al. Recessive osteogenesis imperfecta caused by LEPRE1 mutations: clinical documentation and identification of the splice form responsible for prolyl 3-hydroxylation. J. Med. Genet. 2009, 46:233-241.